GAIN THERAPEUTICS, INC Increase (Decrease) in Accounts Payable
GAIN THERAPEUTICS, INC (GANX) reported Increase (Decrease) in Accounts Payable of -$643.16 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2024-03-26
- GAIN THERAPEUTICS, INC increase (decrease) in accounts payable for the quarter ending 2022-03-31 was $1.54M, a 1761.80% increase year-over-year.
- GAIN THERAPEUTICS, INC increase (decrease) in accounts payable for the quarter ending 2021-03-31 was $82.93K.
- GAIN THERAPEUTICS, INC increase (decrease) in accounts payable for fiscal 2023 was -$643.16K, a 160.29% decline from fiscal 2022.
- GAIN THERAPEUTICS, INC increase (decrease) in accounts payable for fiscal 2022 was $1.07M.
- GAIN THERAPEUTICS, INC increase (decrease) in accounts payable for fiscal 2021 was -$521.39K, a 231.82% decline from fiscal 2020.
- GAIN THERAPEUTICS, INC increase (decrease) in accounts payable for fiscal 2020 was $395.54K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|
| 2023-12-31 | -$643.16K 10-K · filed 2024-03-26 | |
| 2022-12-31 | $1.07M 10-K · filed 2024-03-26 | |
| 2022-03-31 | $1.54M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | -$521.39K 10-K · filed 2023-03-23 | |
| 2021-03-31 | $82.93K 10-Q · filed 2022-05-16 | |
| 2020-12-31 | $395.54K 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |